Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows (unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (unaudited) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 28, 2013
Dec. 29, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net income $ 37,984 $ 37,398 $ 37,677
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 7,227 7,186 6,721
(Gain)Loss on disposal of assets 462 193 (32)
Gain on investment in business (528) 0 (1,244)
Stock compensation income tax benefit 3,047 2,333 1,752
Deferred director and phantom stock unit expense (income) 70 20 (22)
Stock compensation income tax benefit (303) (88) (144)
Deferred director and phantom stock unit expense (income) (7) 26 1
Provision for slow moving inventory 0 112 19
Provision for Deferred Income Taxes 291 325 1,419
(Increase) decrease in, net of acquisition:      
Accounts receivable (3,210) 1,903 741
Inventories (1,226) 268 (1,631)
Income taxes receivable 77 (520) 1,178
Other current assets (167) (650) (662)
Other assets 383 240 (1,081)
Increase (decrease) in, net of acquisition:      
Accounts payable 24 (742) 499
Accrued expenses and other liabilities 3,155 4,547 4,390
Other noncurrent liabilities (156) (353) (37)
Net cash provided by operating activities 47,123 52,198 49,544
Cash flows from investing activities:      
Proceeds from sale of joint venture 0 0 1,451
Investment in business, net of cash acquired (923) (1,140) (1,776)
Capital expenditures (17,935) (13,359) (10,143)
Proceeds from dispositions of equipment 230 56 35
Purchases of short-term investments (28,356) (40,495) (26,833)
Proceeds from sale of short-term investments 26,764 32,912 7,517
Net cash used in investing activities (20,220) (22,026) (29,749)
Cash flows from financing activities:      
Repayment of debt 0 (169) (100)
Stock compensation income tax benefit 0 0 61
Stock compensation income tax benefit 303 88 144
Proceeds from stock issued 859 700 574
Dividends to shareholders (9,435) (40,900) (9,596)
Change in restricted cash (5) (272) 84
Net cash used in financing activities (8,278) (40,553) (8,833)
Effect of exchange rate changes on cash and cash equivalents 1,809 2,025 (1,334)
Net increase (decrease) in cash and cash equivalents 20,434 (8,356) 9,628
Cash and cash equivalents, beginning of period 34,478 42,834 33,206
Cash and cash equivalents, end of period 54,912 34,478 42,834
Cash paid:      
Income taxes 19,123 18,739 17,456
Supplemental disclosure of noncash transactions:      
Common stock issued for shared distribution through accrued expenses and other liabilities 3,486 4,407 2,412
Common stock issued for deferred director’s compensation through other noncurrent liabilities 294 930 0
Unrealized gain (loss) on available for sale securities $ (22) $ 326 $ (549)